- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Monitoring of anti-TNF biological treatments ; volume:8 ; number:1 ; day:25 ; month:11 ; year:2010 ; pages:1 ; date:11.2010
Journal of translational medicine ; 8, Heft 1 (25.11.2010), 1, 11.2010
- Urheber
-
Ruiz del Agua, A.
- Beteiligte Personen und Organisationen
-
Pascual-Salcedo, D.
Balsa, A.
RAMOS, I.
Novalbos, L.
Ramiro, S.
Martinez, A.
Simon, L.
Nagore, D.
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-8-S1-P32
- URN
-
urn:nbn:de:1111-2016041436059
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ruiz del Agua, A.
- Pascual-Salcedo, D.
- Balsa, A.
- RAMOS, I.
- Novalbos, L.
- Ramiro, S.
- Martinez, A.
- Simon, L.
- Nagore, D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
A review of ocular adverse events of biological anti-TNF drugs
Stopping Anti-TNF in CD Remitters: Cons
Development of anti-TNF antibody-gold nanoparticles (anti-TNF-AuNPs)
Anti-TNF, a magic bullet in cancer immunotherapy?
Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment
Predictors of response and anti-TNF drugs comparative efficacy
Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy
The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
Predictive biomarkers for anti-TNF alpha therapy in IBD patients
Lack of replication of genetic predictors for the rheumatoid arthritis response to anti-TNF treatments: a prospective case-only study
Der molekulare Wirkmechanismus der anti-TNF Antikörper bei chronisch entzündlichen Darmerkrankungen
Anti-TNF Exposure during Pregnancy in Crohn’s Disease Patients
A review of ocular adverse events of biological anti-TNF drugs
Stopping Anti-TNF in CD Remitters: Cons
Development of anti-TNF antibody-gold nanoparticles (anti-TNF-AuNPs)
Anti-TNF, a magic bullet in cancer immunotherapy?
Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment
Predictors of response and anti-TNF drugs comparative efficacy
Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy
The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
Predictive biomarkers for anti-TNF alpha therapy in IBD patients
Lack of replication of genetic predictors for the rheumatoid arthritis response to anti-TNF treatments: a prospective case-only study
Der molekulare Wirkmechanismus der anti-TNF Antikörper bei chronisch entzündlichen Darmerkrankungen
Anti-TNF Exposure during Pregnancy in Crohn’s Disease Patients
A review of ocular adverse events of biological anti-TNF drugs
Stopping Anti-TNF in CD Remitters: Cons
Development of anti-TNF antibody-gold nanoparticles (anti-TNF-AuNPs)
Anti-TNF, a magic bullet in cancer immunotherapy?
Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment
Predictors of response and anti-TNF drugs comparative efficacy
Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy
The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
Predictive biomarkers for anti-TNF alpha therapy in IBD patients
Lack of replication of genetic predictors for the rheumatoid arthritis response to anti-TNF treatments: a prospective case-only study
Der molekulare Wirkmechanismus der anti-TNF Antikörper bei chronisch entzündlichen Darmerkrankungen